IBDEI0YP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16916,0)
 ;;=473.9^^87^1028^64
 ;;^UTILITY(U,$J,358.3,16916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16916,1,3,0)
 ;;=3^473.9
 ;;^UTILITY(U,$J,358.3,16916,1,4,0)
 ;;=4^Sinusitis, Chronic
 ;;^UTILITY(U,$J,358.3,16916,2)
 ;;=Sinusitis, Chronic^123985
 ;;^UTILITY(U,$J,358.3,16917,0)
 ;;=463.^^87^1028^68
 ;;^UTILITY(U,$J,358.3,16917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16917,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,16917,1,4,0)
 ;;=4^Tonsillitis, Acute
 ;;^UTILITY(U,$J,358.3,16917,2)
 ;;=Tonsillitis, Acute^2695
 ;;^UTILITY(U,$J,358.3,16918,0)
 ;;=465.9^^87^1028^69
 ;;^UTILITY(U,$J,358.3,16918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16918,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,16918,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,16918,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,16919,0)
 ;;=478.30^^87^1028^72
 ;;^UTILITY(U,$J,358.3,16919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16919,1,3,0)
 ;;=3^478.30
 ;;^UTILITY(U,$J,358.3,16919,1,4,0)
 ;;=4^Vocal Cord Paralysis
 ;;^UTILITY(U,$J,358.3,16919,2)
 ;;=Vocal Cord Paralysis^127133
 ;;^UTILITY(U,$J,358.3,16920,0)
 ;;=018.90^^87^1028^27
 ;;^UTILITY(U,$J,358.3,16920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16920,1,3,0)
 ;;=3^018.90
 ;;^UTILITY(U,$J,358.3,16920,1,4,0)
 ;;=4^Miliary TB
 ;;^UTILITY(U,$J,358.3,16920,2)
 ;;=^122716
 ;;^UTILITY(U,$J,358.3,16921,0)
 ;;=137.0^^87^1028^31
 ;;^UTILITY(U,$J,358.3,16921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16921,1,3,0)
 ;;=3^137.0
 ;;^UTILITY(U,$J,358.3,16921,1,4,0)
 ;;=4^Old TB
 ;;^UTILITY(U,$J,358.3,16921,2)
 ;;=Late Effect of TB^266974
 ;;^UTILITY(U,$J,358.3,16922,0)
 ;;=010.00^^87^1028^61
 ;;^UTILITY(U,$J,358.3,16922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16922,1,3,0)
 ;;=3^010.00
 ;;^UTILITY(U,$J,358.3,16922,1,4,0)
 ;;=4^Primary TB Infection
 ;;^UTILITY(U,$J,358.3,16922,2)
 ;;=^265990
 ;;^UTILITY(U,$J,358.3,16923,0)
 ;;=011.90^^87^1028^67
 ;;^UTILITY(U,$J,358.3,16923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16923,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,16923,1,4,0)
 ;;=4^TB, Active
 ;;^UTILITY(U,$J,358.3,16923,2)
 ;;=TB, Active^122756
 ;;^UTILITY(U,$J,358.3,16924,0)
 ;;=010.10^^87^1028^66
 ;;^UTILITY(U,$J,358.3,16924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16924,1,3,0)
 ;;=3^010.10
 ;;^UTILITY(U,$J,358.3,16924,1,4,0)
 ;;=4^TB Pleurisy
 ;;^UTILITY(U,$J,358.3,16924,2)
 ;;=TB Pleurisy^265999
 ;;^UTILITY(U,$J,358.3,16925,0)
 ;;=491.22^^87^1028^10
 ;;^UTILITY(U,$J,358.3,16925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16925,1,3,0)
 ;;=3^491.22
 ;;^UTILITY(U,$J,358.3,16925,1,4,0)
 ;;=4^COPD w/ Acute Bronchitis
 ;;^UTILITY(U,$J,358.3,16925,2)
 ;;=^331455
 ;;^UTILITY(U,$J,358.3,16926,0)
 ;;=795.51^^87^1028^60
 ;;^UTILITY(U,$J,358.3,16926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16926,1,3,0)
 ;;=3^795.51
 ;;^UTILITY(U,$J,358.3,16926,1,4,0)
 ;;=4^Positive PPD
 ;;^UTILITY(U,$J,358.3,16926,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,16927,0)
 ;;=031.9^^87^1028^4
 ;;^UTILITY(U,$J,358.3,16927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16927,1,3,0)
 ;;=3^031.9
 ;;^UTILITY(U,$J,358.3,16927,1,4,0)
 ;;=4^Atypical Mycobacteria
 ;;^UTILITY(U,$J,358.3,16927,2)
 ;;=^123817
 ;;^UTILITY(U,$J,358.3,16928,0)
 ;;=480.0^^87^1028^37
 ;;^UTILITY(U,$J,358.3,16928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16928,1,3,0)
 ;;=3^480.0
 ;;^UTILITY(U,$J,358.3,16928,1,4,0)
 ;;=4^Pneumonia d/t Adenovirus
 ;;^UTILITY(U,$J,358.3,16928,2)
 ;;=^269928
 ;;^UTILITY(U,$J,358.3,16929,0)
 ;;=480.1^^87^1028^52
 ;;^UTILITY(U,$J,358.3,16929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16929,1,3,0)
 ;;=3^480.1
 ;;
 ;;$END ROU IBDEI0YP
